Search results
Atrial High-rate Episodes: A Systematic Review and Meta-analysis
Author(s):
Hasaan Ahmed
,
Mahmoud Ismayl
,
Anirudh Palicherla
,
et al
Added:
1 year ago
Systematic Review
Atrial Cardiomyopathy and AF in Heart Failure Substrates
Author(s):
Bharat K Kantharia
,
Lingling Wu
,
Mohit M Hulsurkar
,
et al
Added:
3 months ago
Review Article
Selecting Patients for AF Ablation in Heart Failure
Author(s):
Aaron A Sifuentes
,
Mohammed Mhanna
,
Paari Dominic
,
et al
Added:
3 weeks ago
Review Article
Author(s):
Riccardo Cappato
,
Rui Providencia
Added:
1 year ago
What updates do ECAS recommend for catheter ablation of atrial fibrillation?In this short interview, Prof Riccardo Cappato (IRCCS Humanitas Research Hospital, Milan, IT) and Prof Rui Providência (St Bartholomew's Hospital, London, UK) discuss new guidelines released by ECAS on catheter ablation for atrial fibrillation (AF). Prof Cappato and Prof Providência explain the need for an updated and…
View more
Author(s):
Benjamin D'Souza
Added:
22 hours ago
In this case, Dr Ben D'Souza (Penn Presbyterian Medical Center, US) presents a patient with long-standing persistent AF who has been in continuous AF for over a year, with a dilated left atrium but preserved ejection fraction. The series follows a substrate-based ablation strategy combining pulmonary vein isolation, posterior wall isolation and an anterior mitral line, with lesion placement…
View more
Medical Therapy of Heart Failure and AF
Author(s):
Gregory Burkman
,
Gerald V Naccarelli
Added:
1 month ago
Review Article
Author(s):
Kenneth Bilchick
Added:
1 month ago
HRS Congress 2026 — Dr Kenneth Bilchick (UVA Heart & Vascular Center, Charlottesville, VA, US) joins us to discuss findings from a study examining whether the protective effect of glucagon-like peptide-1 (GLP-1) receptor agonists on atrial fibrillation risk operates independently of weight loss and survival.Interview Questions:What is the current understanding of how GLP-1 receptor agonists may…
View more
Author(s):
Renato D Lopes
Added:
1 year ago
ESC Congress 24 — AF screening with a wearable ECG device increases diagnosis by over 50% but did not significantly reduce hospitalisation rates for stroke.We are joined onsite at ESC Congress 2024 by Dr Renato Lopes (Duke University Medical Center, NC) to discuss the findings from the GUARD-AF Trial (NCT04126486, Bristol-Myers Squibb), which was designed to determine if screening for undiagnosed…
View more